Gilles C Martin1, Charlotte Dénier1, Olivia Zambrowski1,2, David Grévent3, Lenaïc Bruère1, Valentine Brousse4, Mariane de Montalembert4, Dominique Brémond-Gignac1,5, Matthieu P Robert1,6. 1. Ophthalmology Department, Necker-Enfants Malades University Hospital, APHP, Paris, France. 2. Ophthalmology Department, Centre hospitalier intercommunal de Créteil, Creteil, France. 3. Radiology Department, Necker-Enfants Malades University Hospital, APHP, Paris, France. 4. Pediatrics Department, Necker-Enfants Malades University Hospital, APHP, Paris, France. 5. CNRS FR3636, Paris Descartes University, Paris, France. 6. Cognition and Action Group, Paris Descartes University, Sorbonne Paris Cité, Paris, France.
Abstract
Importance: Temporal macular involvement in sickle cell disease can now easily be detected by optical coherence tomography (OCT). However, while recent studies have demonstrated its high prevalence, little is known about its potential consequences on visual function. Objective: To assess the visual function of patients with sickle cell disease with no visual symptoms despite temporal macular atrophy. Design, Setting, and Participants: This retrospective case series included data collection and explorations made in a single referral center for sickle cell disease in 2016. Three patients with sickle cell disease exhibiting preserved visual acuity but showing temporal macular retinal atrophy were included. Exposures: Patients underwent the following explorations: best-corrected distance and near visual acuity evaluation; dilated fundus examination; OCT with 12 × 6-mm thickness map; horizontal, vertical, and en face sections; OCT angiography of the 6 × 6-mm perifoveal retina; 30° and 12° central visual fields; Lanthony 15-hue color vision test; automated static contrast sensitivity test; and global electroretinography. Main Outcomes and Measures: The OCT thickness maps were checked for areas of retinal thinning, appearing as blue patches. When present, these areas were compared with the areas of superficial and deep capillary flow loss on OCT angiography and with the scotomas on visual fields. Contrast sensitivity and color vision loss were quantified. Results: All 3 patients included had homozygous sickle cell disease. They presented with a 20/20 distance visual acuity, and Parinaud 1,5 near visual acuity in both eyes. They were all followed up for a severe cerebral vasculopathy related to sickle cell disease. The areas of atrophy involved the inner retinal layers and were associated with an absence of signal in the deep capillary plexuses in OCT angiography. These patches of retinal thinning were also matching with scotomas in the automated visual fields. Color vision ability and contrast sensitivity were impaired in all patients. Global electroretinography findings were normal. Conclusions and Relevance: Temporal macular atrophy in sickle cell disease may have direct consequences on visual function, including in children, even when visual acuity is preserved. Optical coherence tomographic imaging may be warranted when evaluating patients with sickle cell disease, even if asymptomatic with 20/20 visual acuity.
Importance: Temporal macular involvement in sickle cell disease can now easily be detected by optical coherence tomography (OCT). However, while recent studies have demonstrated its high prevalence, little is known about its potential consequences on visual function. Objective: To assess the visual function of patients with sickle cell disease with no visual symptoms despite temporal macular atrophy. Design, Setting, and Participants: This retrospective case series included data collection and explorations made in a single referral center for sickle cell disease in 2016. Three patients with sickle cell disease exhibiting preserved visual acuity but showing temporal macular retinal atrophy were included. Exposures: Patients underwent the following explorations: best-corrected distance and near visual acuity evaluation; dilated fundus examination; OCT with 12 × 6-mm thickness map; horizontal, vertical, and en face sections; OCT angiography of the 6 × 6-mm perifoveal retina; 30° and 12° central visual fields; Lanthony 15-hue color vision test; automated static contrast sensitivity test; and global electroretinography. Main Outcomes and Measures: The OCT thickness maps were checked for areas of retinal thinning, appearing as blue patches. When present, these areas were compared with the areas of superficial and deep capillary flow loss on OCT angiography and with the scotomas on visual fields. Contrast sensitivity and color vision loss were quantified. Results: All 3 patients included had homozygous sickle cell disease. They presented with a 20/20 distance visual acuity, and Parinaud 1,5 near visual acuity in both eyes. They were all followed up for a severe cerebral vasculopathy related to sickle cell disease. The areas of atrophy involved the inner retinal layers and were associated with an absence of signal in the deep capillary plexuses in OCT angiography. These patches of retinal thinning were also matching with scotomas in the automated visual fields. Color vision ability and contrast sensitivity were impaired in all patients. Global electroretinography findings were normal. Conclusions and Relevance: Temporal macular atrophy in sickle cell disease may have direct consequences on visual function, including in children, even when visual acuity is preserved. Optical coherence tomographic imaging may be warranted when evaluating patients with sickle cell disease, even if asymptomatic with 20/20 visual acuity.
Authors: F Bernaudin; S Verlhac; F Fréard; F Roudot-Thoraval; M Benkerrou; I Thuret; R Mardini; J P Vannier; E Ploix; M Romero; C Cassé-Perrot; M Helly; E Gillard; G Sebag; H Kchouk; J P Pracros; B Finck; J N Dacher; V Ickowicz; C Raybaud; M Poncet; E Lesprit; P H Reinert; P Brugières Journal: J Child Neurol Date: 2000-05 Impact factor: 1.987
Authors: G K Asdourian; K C Nagpal; B Busse; M Goldbaum; D Patriankos; M F Rabb; M F Goldberg Journal: Br J Ophthalmol Date: 1976-06 Impact factor: 4.638
Authors: Daphne L McCulloch; Michael F Marmor; Mitchell G Brigell; Ruth Hamilton; Graham E Holder; Radouil Tzekov; Michael Bach Journal: Doc Ophthalmol Date: 2014-12-14 Impact factor: 2.379
Authors: Khalil Ghasemi Falavarjani; Adrienne W Scott; Kang Wang; Ian C Han; Xuejing Chen; Michael Klufas; Jean-Pierre Hubschman; Steven D Schwartz; Srinivas R Sadda; David Sarraf; Irena Tsui Journal: Retina Date: 2016-12 Impact factor: 4.256
Authors: Wilfried Minvielle; Violaine Caillaux; Salomon Y Cohen; François Chasset; Olivia Zambrowski; Alexandra Miere; Eric H Souied Journal: Am J Ophthalmol Date: 2015-12-31 Impact factor: 5.258
Authors: Davis B Zhou; Maria V Castanos; Alexander Pinhas; Peter Gillette; Justin V Migacz; Richard B Rosen; Jeffrey Glassberg; Toco Y P Chui Journal: Biomed Opt Express Date: 2021-04-21 Impact factor: 3.732
Authors: Laura Dell'Arti; Giulio Barteselli; Lorenzo Riva; Elisa Carini; Giovanna Graziadei; Eleonora Benatti; Alessandro Invernizzi; Maria D Cappellini; Francesco Viola Journal: PLoS One Date: 2018-03-01 Impact factor: 3.240